No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
EGYPT – Alameda Healthcare Group has signed a new seven-year strategic partnership agreement with Siemens Healthineers to transform the healthcare landscape in Egypt. Under this collaboration, Alameda Healthcare Group and…
Read More
INDIA – Alkem Laboratories is eyeing an international expansion of its active pharmaceutical ingredients (API) business under its own brand name, Alkem Activa. To Alkem Laboratories, Alkem Activa represents a…
Read More
INDIA – Cipla Limited, in partnership with Skye Air Mobility, has introduced a drone services network exclusively designed to serve the healthcare needs of the Indian state of Himachal Pradesh.…
Read More
USA —Abbott Laboratories, Inc. has concluded its acquisition of Bigfoot Biomedical—an innovative force in intelligent insulin management systems. While financial specifics remain undisclosed, the implications of this union are profound.…
Read More
UAE – Emirates Health Services has entered into a strategic partnership agreement with Care.ai to deploy the latter’s Artificial Intelligence-powered system for enhancing patient health monitoring. Under the terms of…
Read More
LIBYA – The Government of the United Kingdom has provided a medical emergency package worth up to £10 million (US$10.58 million) to boost emergency response activities for Libyan flood victims…
Read More
TUNISIA – Pharmaceutical imports have risen by 44%, from TND1,228.6 million (US$389.78 million) in 2018 to TND1,764 million (US$559.64 million) in 2022, over the last five years, reports the Central…
Read More
EGYPT – The Egyptian Ministry of Planning and Economic Development (MPED) is allocating EGP 75 billion (US$2.43 billion) of its budget for the current fiscal year (FY) 2023/2024 for the…
Read More
SAUDI ARABIA – Professional Medical Expertise Company (ProMedEx) has entered into a SAR 50 million (US$13.33 million) multi-purpose financing agreement with Banque Saudi Fransi. ProMedEx is a renowned medical devices…
Read More
INDIA — In a bold and strategic move, Glenmark Pharmaceuticals, a leading generics producer, is divesting a significant portion of its active pharmaceutical ingredient (API) business. The company is selling…
Read More